These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11907635)
1. Is it rational, reasonable or excessive, and consistently applied? One view of the increasing FDA emphasis on safety first for the release and use of antiarrhythmic drugs for supraventricular arrhythmias. Reiffel JA J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):333-9. PubMed ID: 11907635 [No Abstract] [Full Text] [Related]
3. Pure class III agents for prevention of sudden cardiac death. Pratt CM J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S82-6. PubMed ID: 12950526 [TBL] [Abstract][Full Text] [Related]
4. [Progress in the clinical use of anti-arrhythmic drugs (I)]. Li WZ Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):735-7. PubMed ID: 14731351 [No Abstract] [Full Text] [Related]
5. New advances in class III antiarrhythmic drug therapy. Sager PT Curr Opin Cardiol; 1999 Jan; 14(1):15-23. PubMed ID: 9932203 [TBL] [Abstract][Full Text] [Related]
6. A benefit-risk assessment of class III antiarrhythmic agents. Elming H; Brendorp B; Pehrson S; Pedersen OD; Køber L; Torp-Petersen C Expert Opin Drug Saf; 2004 Nov; 3(6):559-77. PubMed ID: 15500415 [TBL] [Abstract][Full Text] [Related]
7. New antiarrhythmic drugs for the treatment of atrial fibrillation. Castro A; Bianconi L; Santini M Pacing Clin Electrophysiol; 2002 Feb; 25(2):249-59. PubMed ID: 11916001 [No Abstract] [Full Text] [Related]
8. New advances in class III antiarrhythmic drug therapy. Sager PT Curr Opin Cardiol; 2000 Jan; 15(1):41-53. PubMed ID: 10666660 [TBL] [Abstract][Full Text] [Related]
9. Azimilide. NE 10064, Stedicor. Drugs R D; 1999 Apr; 1(4):297-300. PubMed ID: 10566048 [No Abstract] [Full Text] [Related]